Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion
Lynn R. Webster(Adherent Technologies (United States)), Theresa Mallick‐Searle(Stanford Health Care), Jeffrey Fudin(University of Connecticut), Jeremy Adler, Jeffrey Gudin(Rutgers, The State University of New Jersey), Jay Kuchera(Calmar Pain Relief), Robert B. Raffa(United Therapeutics (United States)), Richard Rauck(Carolinas Pain Institute)
Cited by 129
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group
|Regional Anesthesia & Pain Medicine|2020|370
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309